DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) had its price objective lowered by Robert W. Baird from $35.00 to $33.00 in a research report report published on Friday morning, Benzinga reports. Robert W. Baird currently has a neutral rating on the medical instruments supplier’s stock. Several other equities analysts also recently weighed in on XRAY. Barrington […]